Key Impacts of the 2026 National AI Legislative Framework on Healthcare

Key Takeaways

• The 2026 national artificial intelligence (“AI”) legislative framework indicates a move toward federal AI legislation and potential preemption of state laws, creating a more uniform and strict compliance environment for healthcare and digital health companies.
• The framework prioritizes innovation alongside safeguards for vulnerable populations, placing heightened scrutiny on healthcare AI tools, especially those involving clinical decision-making, patient interaction, and minors.
• Providers and technology companies should implement mature AI governance now, including inventorying AI assets, tightening oversight, and documenting bias‑mitigation efforts, to meet future federal requirements and enforcement expectations.

What Is the 2026 National AI Legislative Framework?

On March 20, 2026, the White House published the national AI legislative framework, outlining the administration’s preferred blueprint for federal AI legislation. One of the framework’s most consequential themes is its explicit rejection of the current and rapidly expanding “patchwork of conflicting state laws” governing AI as contrary to innovation. Instead, the framework calls for a consistent national policy.  The framework adopts an innovation‑forward posture, though it contemplates baseline guardrails for certain higher‑risk AI endeavors.

The framework focuses on seven core pillars:

1. Protecting vulnerable populations such as children.
2. Streamlining critical infrastructure.
3. Reinforcing intellectual property rights.
4. Preventing censorship and protecting free speech.
5. Promoting innovation and economic competitiveness.
6. Developing an AI‑ready workforce.
7. Establishing a federal policy framework.

Federal Preemption and the “Patchwork” Problem

Currently, AI-enabled healthcare providers and health technology companies must navigate a complex web of federal and state laws and agency guidance addressing overlapping topics. including but not limited to privacy, security, data privacy, AI disclosures, practice of medicine, billing, and reimbursement. This rapidly expanding and ever-evolving patchwork of rules and best practices complicates compliance for companies operating nationally.

The framework suggests that states should not unduly burden AI development or advancement. Interestingly, the administration explicitly rejects a new federal rulemaking body in favor of sector-specific AI regulation, application and industry-led standards. However, the framework is careful to acknowledge that widespread innovation cannot be accomplished without the need for certain industry specific federal guardrails.

For example, healthcare is squarely implicated in the framework’s emphasis on protecting children and other vulnerable populations from AI‑related harms, highlighting concerns about minors’ access to AI systems, including AI companions, and the need for heightened oversight measures. The framework indicates support for heightened standards when AI tools are “reasonably likely” to be used by minors, including stronger transparency and content safeguards.

Healthcare organizations deploying AI tools, particularly those touching behavioral health, adolescents, or other vulnerable groups, should anticipate more explicit federal expectations around testing, monitoring, and documenting how they identify and mitigate potential harms.

How the Framework Accelerates AI Adoption in Healthcare and Digital Health

A central purpose of the framework is to “accelerate the deployment of AI across industry sectors.” The framework encourages a furtherance of innovation opportunities to assist with the rapid AI deployment including streamlining of federal permitting, widespread adoption of regulatory sandbox initiatives, increased access to certain federal data sets in AI-ready formats for development and training of AI models and tools, and AI-related funding opportunities including grants, tax incentives, and assistance programs.

For the healthcare industry, this publication serves as an endorsement of continued investment in AI-use cases including AI‑enabled clinical decision support, workflow automation, revenue cycle tools, patient engagement technologies, and population health analytics. The framework suggests that any federal statutory scheme should encourage responsible innovation, provide legal certainty for developers and users, and avoid overbroad restrictions that could stall beneficial use cases.

At the same time, AI acceleration will almost certainly be conditioned on demonstrable industry-specific safeguards. Healthcare providers and technology companies that invest now in robust AI governance, documentation, and oversight will be better positioned to leverage AI’s benefits while meeting the expectations of future national legislation and current state laws and agency oversight.

How Healthcare and Digital Health Companies Can Prepare for Federal AI Regulation

AGG’s Healthcare and Privacy & Cybersecurity teams advise providers, digital health innovators, investors, and vendors on AI governance, contracting, regulatory risk, and product design.

We are closely tracking federal and state AI developments and can assist with AI inventories and risk assessments, policy development, evaluation of AI‑enabled tools, and alignment of your AI strategy with emerging legal requirements. For more information, please contact AGG Healthcare partner Charmaine Mech Aguirre.